Mak, Koon-Hou <br/><br/>
Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study.  [electronic resource] 

 -  American heart journal  Apr 2009 
 - 658-65 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2008.08.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Atherosclerosis--drug therapy<br/>Cause of Death--trends<br/>Clopidogrel<br/>Double-Blind Method<br/>Ethnicity<br/>Female<br/>Follow-Up Studies<br/>Hemorrhage--ethnology<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Myocardial Ischemia--ethnology<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Prognosis<br/>Prospective Studies<br/>Risk Factors<br/>Stroke--ethnology<br/>Ticlopidine--adverse effects<br/>Time Factors<br/>United States